Variations in pharmacy-based transition-of-care activities in the United States: A national survey

American Journal of Health-System Pharmacy

Volumn 71, Issue 8, 2014, Pages 648-656

  Kern, Kristine A ^a   Kalus, James S ^b   Bush, Colleen ^c   Chen, David ^c   Szandzik, Edward G ^b   Haque, Nadia Z ^b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; DIGOXIN; DOFETILIDE; DRUGS USED IN THE TREATMENT OF ADDICTION; ENOXAPARIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; PSYCHOTROPIC AGENT; VACCINE; WARFARIN;

ARTICLE; CLINICAL HANDOVER; COUNSELING; FOLLOW UP; HEALTH CARE EXECUTIVE; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERHOSPITAL COOPERATION; MANAGER; MEDICAL HISTORY; MEDICAL SOCIETY; MEDICAL STAFF; MEDICATION COMPLIANCE; MEDICATION COUNSELING; MEDICATION THERAPY MANAGEMENT; NORMAL HUMAN; NURSE; NURSING STAFF; PATIENT CARE; PATIENT EDUCATION; PATIENT TRANSPORT; PERSONNEL SHORTAGE; PHARMACIST; PHARMACY; PHARMACY STUDENT; PHARMACY TECHNICIAN; PHYSICIAN; SMOKING CESSATION; TRANSITION OF CARE; UNITED STATES; ANAMNESIS; HEALTH CARE ORGANIZATION; HOSPITAL PHARMACY; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; STATISTICS AND NUMERICAL DATA;

CONTINUITY OF PATIENT CARE; HEALTH CARE SURVEYS; HUMANS; MEDICAL HISTORY TAKING; MEDICATION ADHERENCE; MEDICATION RECONCILIATION; PATIENT DISCHARGE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; SOCIETIES, PHARMACEUTICAL; UNITED STATES;

EID: 84907214074     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp130510     Document Type: Article

References (25)

1. Coleman EA, Boult C. Improving the quality of transitional care for persons with complex care needs. J Am Geriatr Soc. 2003; 51:556-7.
2. Forster AJ, Murff HJ, Peterson JF et al. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003; 138:161-7.
3. Boockvar K, Fishman E, Kyriacou CK et al. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med. 2004; 164:545-50.
4. Rozich JD, Resar RK. Medication safety: one organization's approach to the challenge. J Clin Outcomes Manag. 2001; 8:27-34.
5. Aspden P, Wolcott JA, Bootman JL et al., eds. Preventing medication errors: quality chasm series. Washington, DC: National Academies Press; 2007.
6. Joint Commission. 2012 National Patient Safety Goals. www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals (accessed 2012 Jun 20).
7. Bracey G, Miller G, Franklin BD et al. The contribution of a pharmacy admissions service to patient care. Clin Med. 2008; 8:53-7.
8. Murphy EM, Oxencis CJ, Klauck JA et al. Medication reconciliation at an academic medical center: implementation of a comprehensive program from admission to discharge. Am J Health-Syst Pharm. 2009; 66:2126-31.
9. Coutsouvelis J, Corallo CE, Dooley MJ et al. Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care units. Support Care Cancer. 2010; 18:811-6.
10. Crotty M, Rowett D, Spurling L et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004; 2:257-64.
11. Walker PC, Bernstein SJ, Tucker-Jones JN et al. Impact of a pharmacist-facilitated hospital discharge program. Arch Intern Med. 2009; 169:2003-10.
12. Schnipper JL, Kirwin JL, Cotugno MC et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006; 166:565-71.
13. American Society of Health-System Pharmacists. Pharmacy Practice Model Summit: executive summary. Am J Health-Syst Pharm. 2011; 68:1079-85.
14. Schillig J, Kaatz S, Hudson M et al. Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med. 2011; 6:322-8.
15. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Health-Syst Pharm. 1992; 49:387-94.
16. Jack BW, Chetty VK, Anthony D et al. A reengineered hospital discharge program to decrease hospitalization: a randomized trial. Ann Intern Med. 2009; 150:178-87.
17. Agency for Healthcare Research and Quality. Hospital survey on patient safety culture: 2011 user comparative database report. www.ahrq.gov/qual/hospsurvey11/hosp11appc.htm (accessed 2012 Jul 30).
18. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360:1418-28.
19. Berenson RA, Paulus RA, Kalman NS. Medicare's readmissions-reduction program - a positive alternative. N Engl J Med. 2012; 366:1364-6.
20. Medicare Payment Advisory Commission. Public meeting; December 15, 2011. www.medpac.gov/transcripts/1215162011.pdf (accessed 2012 Sep 27).
21. Gattis WA, O'Connor CM, Gallup DS et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol. 2004; 43:1534-41.
22. Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010; 30:330-8.
23. Makowski CT, Jennings DL, Nemerovski CW et al. The impact of pharmacist-directed patient education and anticoagulant care coordination on patient satisfaction. Ann Pharmacother. 2013; 47:805-10.
24. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med. 1999; 159:1939-45.
25. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003; 163:2014-8.